ST PharmLtd Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Peter Kim
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 0.0005% |
| Management average tenure | 1.3yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem
Mar 22
ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected
Mar 18Investors Who Bought ST PharmLtd (KOSDAQ:237690) Shares A Year Ago Are Now Up 221%
Mar 16Calculating The Fair Value Of ST Pharm Co.,Ltd. (KOSDAQ:237690)
Jan 22What Type Of Shareholders Own The Most Number of ST Pharm Co.,Ltd. (KOSDAQ:237690) Shares?
Dec 23Health Check: How Prudently Does ST PharmLtd (KOSDAQ:237690) Use Debt?
Nov 26
CEO
Peter Kim (60 yo)
no data
Tenure
Dr. Kyeong-Jin Kim, also known as Peter, served as Research Director at ST Pharm Co. Ltd. and served as its Vice President of R&D. Dr. Kim is Chief Executive Officer and Inside Director at ST Pharm Co.,Ltd...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Inside Director | no data | no data | 0.00053% ₩ 8.6m | |
| Head of Management Support Division & Inside Director | no data | no data | no data | |
| Senior VP & Head of Business Development Division | no data | no data | 0.11% ₩ 1.7b | |
| Senior VP & Head of Business Management | no data | no data | 0% ₩ 0 | |
| VP and Head of Synthetic R&D Center | 3.3yrs | no data | 0.057% ₩ 930.7m | |
| Senior VP & Head of Manufacturing Division | 1.3yrs | no data | no data | |
| Senior VP and Head of Biotech R&D Division | 1.3yrs | no data | 0.090% ₩ 1.5b | |
| Senior VP & Head of Corporate Quality Division | no data | no data | no data |
1.3yrs
Average Tenure
55yo
Average Age
Experienced Management: A237690's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.